[1]李世伦,李一男,倪其泓,等.下肢静脉疾病介入术后的药物治疗方案[J].介入放射学杂志,2023,32(07):715-718.
　LI Shilun,LI Yinan,NI Qihong,et al.Medication regimen for lower extremity venous diseases after endovascular interventional surgery[J].journal interventional radiology,2023,32(07):715-718.

点击复制

下肢静脉疾病介入术后的药物治疗方案()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］ 中华医学会外科学分会血管外科学组，中国医师协会血管外科医师分会，中国医疗保健国际交流促进会血管外科分会，等．中国慢性静脉疾病诊断与治疗指南［J］． 中华医学杂志， 2019：3047- 3061．
［2］ Kruger PC，Eikelboom JW，Douketis JD，et al. Deep vein thrombosis： update on diagnosis and management［J］. Med J Aust， 2019， 210： 516- 524.
［3］ Gu J，Xu K，Teng G. Consensus among Chinese experts on standard interventional therapy for deep venous thrombosis of lower extremity（second edition）［J］. J Interv Med， 2018， 1： 125- 136.
［4］ 中国医师协会介入医师分会，中华医学会放射学分会介入专业委员会，中国静脉介入联盟，等.下肢深静脉血栓形成介入治疗规范的专家共识（第2版）［J］.中华医学杂志， 2018， 98：1813- 1821.
［5］ Di Minno A， Frigerio B， Spadarella G， et al. Old and new oral anticoagulants：food，herbal medicines and drug interactions［J］. Blood Rev， 2017， 31： 193- 203.
［6］ Du J，Nie M，Yan Z，et al. Safety and efficacy of rivaroxaban for inferior vena cava thrombosis after successful catheter- directed thrombolysis［J］. Semin Thromb Hemost，2022，48：459- 464..
［7］ Endo M，Jahangiri Y，Horikawa M，et al. Antiplatelet therapy is associated with stent patency after iliocaval venous stenting［J］. Cardiovasc Intervent Radiol， 2018， 41： 1691- 1698.
［8］ Sebastian T，Engelberger RP，Spirk D，et al. Cessation of anticoa- gulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis［J］. Vasa， 2019， 48：331- 339.
［9］ 李晓强，张福先，王深明. 深静脉血栓形成的诊断和治疗指南（第三版）［J］. 中国血管外科杂志（电子版）， 2017， 9：250- 257.
［10］ De Maeseneer MG，Kakkos SK，Aherne T，et al. Editor’s choice - European Society for Vascular Surgery（ESVS） 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs［J］. Eur J Vasc Endovasc Surg， 2022，63： 184- 267.
［11］ Douketis JD. The 2016 American college of chest physicians treatment guidelines for venous thromboembolism： a review and critical appraisal［J］. Intern Emerg Med， 2016， 11： 1031- 1035.
［12］ Raju S. Best management options for chronic iliac vein stenosis and occlusion［J］. J Vasc Surg， 2013， 57： 1163- 1169.
［13］ Wittens C， Davies AH， Bakgaard N， et al. Editor’s choice- management of chronic venous disease［J］. Eur J Vasc Endovasc Surg， 2015， 49： 678- 737.
［14］ Chitsike RS，Rodger MA，Kovacs MJ， et al. Risk of post- thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis： results from the REVERSE study［J］. J Thromb Haemost， 2012， 10： 2039- 2044.
［15］ Van Dongen CJ， Prandoni P，Frulla M，et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome［J］. J Thromb Haemost， 2005， 3： 939- 942.
［16］ Hays K，Jolly M，Silver M，et al. Outcomes of endovascular venous stenting in patients on direct oral anticoagulants and antiplatelet therapy at a tertiary referral center［J］. J Vasc Surg Venous Lymphat Disord， 2021， 9： 753- 759.
［17］ Attaran RR，Ozdemir D，Lin IH，et al. Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting： factors associated with stent occlusion［J］. J Vasc Surg Venous Lymphat Disord， 2019， 7： 527- 534.
［18］ Mansilha A， Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy［J］. Int J Mol Sci， 2018， 19： 1669.
［19］ Bignamini AA， Matuska J. Sulodexide for the symptoms and signs of chronic venous disease： a systematic review and meta- analysis［J］. Adv Ther， 2020， 37： 1013- 1033.
［20］ Nicolaides A，Kakkos S，Baekgaard N，et al. Management of chronic venous disorders of the lower limbs. guidelines according to scientific evidence. Part I ［J］. Int Angiol，2018 ，37：181- 254.
［21］ Wu B，Lu J，Yang M，et al. Sulodexide for treating venous leg ulcers［J］. Cochrane Database Syst Rev， 2016， 2016：CD010694.
［22］ Razavi MK， Jaff MR， Miller LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction： systematic review and meta- analysis［J］. Circ Cardiovasc Interv， 2015， 8：e002772.
［23］ Kuetting D， Luetkens J， Wolter K， et al. Catheter- directed thrombectomy for highly symptomatic patients with iliofemoral deep venous thrombosis not responsive to conservative treatment［J］. Cardiovasc Intervent Radiol， 2020， 43： 556- 564.
［24］ 利 峰，杨孔武，穆茂媛，等． 介入综合治疗Cockett综合征伴急性左下肢深静脉血栓形成［J］． 介入放射学杂志， 2021， 30：181- 185．
［25］ Kibrik P，Eisenberg J，Alsheekh A，et al. Safety and efficacy of stenting nonthrombotic iliac vein lesions in octogenarians and nonagenarians in an office setting［J］. Vascular， 2018， 26： 70- 74.
［26］ Gagne PJ，Gagne N，Kucher T，et al. Long- term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction［J］. J Vasc Surg Venous Lymphat Disord， 2019， 7： 45- 55.